Associated Papers
Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines.
da Silva-Oliveira RJ et al.
International Journal of Molecular Sciences, 2022
Select a paper to view details